We are live on ! Find out more
BFC

Blue Fin Capital Portfolio holdings

AUM $692M
1-Year Est. Return 27.29%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+27.29%
3 Year Est. Return
+125.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+590.83%
AUM
$526M
AUM Growth
+$25.4M
Cap. Flow
+$5.34M
Cap. Flow %
1.02%
Top 10 Hldgs %
55.15%
Holding
147
New
4
Increased
55
Reduced
57
Closed
8

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.34M
2
CRM icon
Salesforce
CRM
+$580K
3
CVS icon
CVS Health
CVS
+$513K
4
SNOW icon
Snowflake
SNOW
+$466K
5
MRNA icon
Moderna
MRNA
+$335K

Sector Composition

Rank Sector Weight
1 Technology 36.99%
2 Financials 11.36%
3 Communication Services 9.08%
4 Healthcare 7.56%
5 Consumer Discretionary 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDG icon
51
TransDigm Group
TDG
$71.3B
$1.84M 0.35%
1,286
+76
+6% +$98.8K
PG icon
52
Procter & Gamble
PG
$345B
$1.78M 0.34%
10,256
-130
-1% -$22.1K
ITOT icon
53
iShares Core S&P Total US Stock Market ETF
ITOT
$97.5B
$1.76M 0.34%
14,049
+381
+3% +$46.1K
IVV icon
54
iShares Core S&P 500 ETF
IVV
$900B
$1.76M 0.33%
3,048
-17
-0.6% -$9.45K
SCHP icon
55
Schwab US TIPS ETF
SCHP
$16.3B
$1.75M 0.33%
65,108
-3,754
-5% -$99.1K
TIP icon
56
iShares TIPS Bond ETF
TIP
$14.5B
$1.71M 0.33%
15,505
-578
-4% -$62.8K
BAC icon
57
Bank of America
BAC
$440B
$1.67M 0.32%
42,104
-4,474
-10% -$179K
PEP icon
58
PepsiCo
PEP
$190B
$1.62M 0.31%
9,527
+20
+0.2% +$3.44K
IBB icon
59
iShares Biotechnology ETF
IBB
$9.39B
$1.53M 0.29%
10,479
-37
-0.4% -$5.35K
AMGN icon
60
Amgen
AMGN
$210B
$1.52M 0.29%
4,711
-113
-2% -$37K
AB icon
61
AllianceBernstein
AB
$3.46B
$1.47M 0.28%
42,116
+1,425
+4% +$48.7K
SHW icon
62
Sherwin-Williams
SHW
$87.8B
$1.41M 0.27%
3,695
+449
+14% +$157K
SPSM icon
63
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.6B
$1.4M 0.27%
30,803
+4,894
+19% +$215K
QQQ icon
64
Invesco QQQ Trust
QQQ
$485B
$1.39M 0.26%
2,840
-130
-4% -$61.5K
KO icon
65
Coca-Cola
KO
$372B
$1.37M 0.26%
19,081
-874
-4% -$59.8K
MCD icon
66
McDonald's
MCD
$191B
$1.33M 0.25%
4,367
-261
-6% -$71.9K
CL icon
67
Colgate-Palmolive
CL
$73.8B
$1.28M 0.24%
12,376
-147
-1% -$15K
FLOT icon
68
iShares Floating Rate Bond ETF
FLOT
$10.3B
$1.28M 0.24%
24,982
+2,666
+12% +$136K
SDY icon
69
State Street SPDR S&P Dividend ETF
SDY
$23.8B
$1.27M 0.24%
8,961
-83
-0.9% -$11.2K
IGV icon
70
iShares Expanded Tech-Software Sector ETF
IGV
$14.4B
$1.27M 0.24%
14,175
-70
-0.5% -$6K
AGG icon
71
iShares Core US Aggregate Bond ETF
AGG
$138B
$1.25M 0.24%
12,329
+33
+0.3% +$3.29K
CVX icon
72
Chevron
CVX
$379B
$1.14M 0.22%
7,758
-37
-0.5% -$5.51K
IEFA icon
73
iShares Core MSCI EAFE ETF
IEFA
$194B
$1.13M 0.21%
14,492
+494
+4% +$37K
BAM icon
74
Brookfield Asset Management
BAM
$82.9B
$1.13M 0.21%
23,793
+165
+0.7% +$6.91K
SO icon
75
Southern Company
SO
$107B
$1.04M 0.2%
11,505
-143
-1% -$12.2K

Similar funds

Blue Fin Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Blue Fin Capital held 147 positions worth $526M, up 5.1% from $501M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Blue Fin Capital's Q3 2024 filing shows 4 new, 55 increased, 57 reduced and 8 closed positions. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 1,471 shares worth $227K. The largest sale was NVIDIA, an estimated $1.34M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Financials and Communication Services.

  • Blue Fin Capital's largest Q3 2024 buy was State Street Health Care Select Sector SPDR ETF: 1,471 shares worth $227K.
  • Blue Fin Capital added most to Arm in Q3 2024, an estimated $2.06M increase.
  • Blue Fin Capital's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $1.34M.
  • Blue Fin Capital fully exited Salesforce in Q3 2024, selling an estimated $580K.
  • Blue Fin Capital's ten largest holdings make up 55% of its $526M portfolio in Q3 2024.
  • Blue Fin Capital opened 4 new positions and closed 8 in Q3 2024.
  • Blue Fin Capital's portfolio value rose 5.1% quarter-over-quarter to $526M.

Based on Blue Fin Capital's 13F filing for Q3 2024, filed 5 Nov 2024.